Central Sensitization Presence on the Results of Shoulder Adhesive Capsulitis
FrozenShoulder
Effects of Central Sensitization Presence on the Results of Shoulder Adhesive Capsulitis Treatment With Physical Therapy Agents and Exercise
2 other identifiers
observational
32
1 country
1
Brief Summary
Patients with adhesive capulitis longlasting more than 3 months were participated in the study. they were divided into two groups whether they have central sensitizaiton or not. Conventional physical therapy responses were measured and compared between two groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 13, 2025
CompletedFirst Posted
Study publicly available on registry
August 20, 2025
CompletedAugust 20, 2025
August 1, 2025
1.4 years
August 13, 2025
August 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Visual Analog Scale
A 10 cm VAS, with known validity and reliability, was used as a self-reported measure for the severity of joint pain.
at baseline (T0), after treatment (T1) and at 2nd week after completion of conventional rehabilitation program (T2)
Shoulder Pain Disability Index (SPADI)
This questionnaire was developed to assess shoulder joint pain and disability. The SPADI has two sections; first section contains 5 questions to evaluate pain, whereas second item contains 8 questions to evaluate disability. Scores vary 0-130 and higher scores indicates high disability rates and pain
at baseline (T0), after treatment (T1) and at 2nd week after completion of conventional rehabilitation program (T2)
Measurement of Shoulder range of motion
The same physician performed the measurement for the joint ranges in each plane of the joint with a goniometer. The goniometer's pivot point was positioned on the lateral projection of the shoulder joint while subjects in supine position. The fixed arm aligned parallel to the axillary lateral midline , while the movable arm tracked the humerus' lateral midline movement towards the axilla. The joint was passively forced to the end of the direction of range and measured twice and the average was taken
at baseline (T0), after treatment (T1) and at 2nd week after completion of conventional rehabilitation program (T2)
Secondary Outcomes (3)
Tampa Kinesiophobia Scale (TKS)
at baseline (T0), after treatment (T1) and at 2nd week after completion of conventional rehabilitation program (T2)
Pain Catastrophizing Scale (PCS)
at baseline (T0), after treatment (T1) and at 2nd week after completion of conventional rehabilitation program (T2).
Beck Depression Inventory (BDI)
at baseline (T0), after treatment (T1) and at 2nd week after completion of conventional rehabilitation program (T2)
Study Arms (2)
Group 1
Adhesive shoulder patients with central sensitization
Group 2
Adhesive capsulitis patients without central sensitization
Eligibility Criteria
Adhesive capsulitis patients aged between 18-80 years, and symptoms ongoing more than 3 months were participated in the study
You may qualify if:
- )patients with adhesive capsulitis between 18-80 years old 2) symptoms ongoing more than 3 months 3) willing to participated in the study
You may not qualify if:
- \) patients with cervical radiculopathy 2) Patients with predisposing factors to adhesive capsulitis, such as diabetes mellitus, thyroid disease, coronary artery disease, lung pathologies or tuberculosis 3) any defined central sensitization syndrome such as fibromiyalgia before 4) presence of rheumatologic diseases 5) pregnancy 6) patients underwent bypass surgery or who have cardiac pacemaker 7) patients with septic arthritis or sepsis 8) malignancy 9) patients that underwent surgery through the shoulder region or had injection through the shoulder joint in the last 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)
Related Publications (3)
Bilika P, Nijs J, Fandridis E, Dimitriadis Z, Strimpakos N, Kapreli E. In the Shoulder or in the Brain? Behavioral, Psychosocial and Cognitive Characteristics of Unilateral Chronic Shoulder Pain with Symptoms of Central Sensitization. Healthcare (Basel). 2022 Aug 30;10(9):1658. doi: 10.3390/healthcare10091658.
PMID: 36141270BACKGROUNDBrindisino F, Girardi G, Crestani M, Fiore A, Giovannico G, Garzonio F, Venturin D, Struyf F. Effectiveness of electrophysical agents in subjects with frozen shoulder: a systematic review and meta-analysis. Disabil Rehabil. 2024 Aug;46(16):3513-3534. doi: 10.1080/09638288.2023.2251880. Epub 2023 Sep 5.
PMID: 37667875BACKGROUNDJames-Belin E, Lasbleiz S, Haddad A, Morchoisne O, Ostertag A, Yelnik A, Laredo JD, Bardin T, Orcel P, Richette P, Beaudreuil J. Shoulder adhesive capsulitis: diagnostic value of active and passive range of motion with volume of gleno-humeral capsule as a reference. Eur J Phys Rehabil Med. 2020 Aug;56(4):438-443. doi: 10.23736/S1973-9087.19.05890-8. Epub 2019 Nov 18.
PMID: 31742369BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Prof
Study Record Dates
First Submitted
August 13, 2025
First Posted
August 20, 2025
Study Start
January 1, 2021
Primary Completion
June 1, 2022
Study Completion
June 1, 2022
Last Updated
August 20, 2025
Record last verified: 2025-08